Association between Rash and a Positive Drug Response Associated with Vinorelbine in a Patient with Primary Peritoneal Carcinoma

Vinorelbine (Navelbine, VRL) is commonly used for platinum-resistant ovarian cancer and has been shown to be effective in patients with recurrent primary peritoneal carcinoma. Of VRL's major side effects, skin rash is uncommon, and, if it does occur, it is usually localized to site of injection...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammad, Mustafa M., Syrigos, Kostas N., Saif, M. Wasif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773891/
https://www.ncbi.nlm.nih.gov/pubmed/24073344
http://dx.doi.org/10.1155/2013/825717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773891/
https://www.ncbi.nlm.nih.gov/pubmed/24073344
http://dx.doi.org/10.1155/2013/825717

Ejemplares similares